heni drugs corp.

p o box 6222
somerset, new jersey 08875

NYS Entity Status
ACTIVE

NYS Filing Date
NOVEMBER 25, 2013

NYS DOS ID#
4491992

County
KINGS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - HENI DRUGS CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Marine Corps Plane Crash: The Victims
    By THE NEW YORK TIMES - Thursday Jul 13, 2017

    Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.

    Source: NYT > Home Page
  • Could the Rockaways Survive Another Sandy?
    By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017

    Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.

    Source: NYT > Home Page
  • Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another
    By Frank Vinluan - Monday Nov 20, 2017

    Acorda Therapeutics said Monday that it will stop work on an experimental treatment for Parkinson’s disease, spelling the end for a drug the Ardsley, NY, company added to its pipeline last year in a $363 million deal. The announcement follows the recent emergence of safety problems for the Acorda (NASDAQ: ACOR) drug, tozadenant. Acorda said […]

    Source: Xconomy New York
  • Most hated man in US soccer accused of ties to drug kingpin
    By Brian Lewis, Kaja Whitehouse - Wednesday Aug 9, 2017

    Rafael “Rafa” Marquez – who played for the NY Red Bulls before becoming captain of Mexico’s National Team – has been secretly acting as a frontman for a Mexican drug kingpin, according to the US Treasury Dept. Marquez, 37, is one of close to two dozen people the Treasury Dept. on Wednesday said has been helping hide...

    Source: New York Post: Sports
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Billionaires, Bruised Egos, and the Death of a Grand Project
    By CHARLES V. BAGLI and ROBIN POGREBIN - Sunday Sep 24, 2017

    Barry Diller was about to win the battle for his $250 million arts pier, but then came the “petty questions” from his opponents and he decided to pull the plug.

    Source: NYT > Home Page